论文部分内容阅读
本文研究核黄素对冠心病患者血小板聚集性的影响。结果发现大剂量核黄素（75mg·d－1）有显著抗血小板聚集作用，且强于阿斯匹林，二组比较Ptmax和PtK有显著差异（P＜0．05）；此外，核黄素还具有明显改善心功能的作用。该研究结果为核黄素作为冠心病的预防药物提供了临床依据。
This article studies the effect of riboflavin on platelet aggregation in patients with coronary heart disease. The results showed that high dose of riboflavin (75 mg · d-1) had significant anti-platelet aggregation effect, which was stronger than aspirin. There was significant difference between Ptmax and PtK in the two groups (P <0.05) Su also significantly improve the function of heart function. The findings provide a clinical basis for riboflavin as a prophylactic agent for coronary heart disease.